Monte Rosa Therapeutics, Inc. (GLUE) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $4.70M | +17.9% |
| 2024 | $3.99M | -79.1% |
| 2023 | $19.04M | +47.5% |
| 2022 | $12.91M | +32.7% |
| 2021 | $9.73M | +187.2% |
| 2020 | $3.39M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $4.70M | +17.9% |
| 2024 | $3.99M | -79.1% |
| 2023 | $19.04M | +47.5% |
| 2022 | $12.91M | +32.7% |
| 2021 | $9.73M | +187.2% |
| 2020 | $3.39M | — |